跳至主要内容
临床试验/IRCT20201128049508N1
IRCT20201128049508N1招募中3 期

Evaluation of statin effect on COVID19 duration and complications

Ghoum University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18
  • No history of statin use in the past
  • Oxygen saturation above 93% by receiving oxygen reservation bag
  • Liver enzymes in the normal range
  • Lack of musculoskeletal disease such as myopathy. Known neuropathy
  • Do not take drugs that interfere with the use of statins as defined by the FDA

排除标准

  • People with kidney disease in the ESRD stage, in other words GFR less than 15
  • Cardiogenic shock
  • Recent acute renal failure-Severe heart-liver failure
  • Patients with transplanted kidney
  • People who have had CT Angio-MR Angio-Angiography in the last 2 weeks.
  • Receiving nephrotoxic substances during the last two weeks
  • Instability of the patient's hemodynamic status
  • History of taking statins
  • Increase CPK (double)AST (triple)
  • SPO2 below 93% despite receiving oxygen reservation bag

研究者

发起方
Ghoum University of Medical Sciences

相似试验